"Polymyositis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)
Descriptor ID |
D017285
|
MeSH Number(s) |
C05.651.594.819 C10.668.491.562.575
|
Concept/Terms |
Polymyositis- Polymyositis
- Polymyositides
- Myositis, Multiple
- Multiple Myositis
- Myositides, Multiple
Polymyositis, Idiopathic- Polymyositis, Idiopathic
- Idiopathic Polymyositides
- Idiopathic Polymyositis
- Polymyositides, Idiopathic
|
Below are MeSH descriptors whose meaning is more general than "Polymyositis".
Below are MeSH descriptors whose meaning is more specific than "Polymyositis".
This graph shows the total number of publications written about "Polymyositis" by people in this website by year, and whether "Polymyositis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 0 | 2 | 2 |
2022 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polymyositis" by people in Profiles.
-
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023 Nov 02; 62(11):3672-3679.
-
Polymyositis/dermatomyositis readmissions: analysis of the nationwide readmission database. Clin Rheumatol. 2023 Oct; 42(10):2833-2839.
-
Reasons for Hospitalization and In-Hospital Mortality in Adults With Dermatomyositis and Polymyositis. J Clin Rheumatol. 2022 03 01; 28(2):e433-e439.
-
Serum transaminases are frequently elevated at time of diagnosis of idiopathic inflammatory myopathy and normalize with creatine kinase. J Clin Rheumatol. 2014 Apr; 20(3):130-2.
-
The utility of serum aldolase in normal creatine kinase dermatomyositis. J Clin Rheumatol. 2014 Jan; 20(1):47-8.
-
Clinical immunopharmacology of autoimmune neuropathies and myopathies. Clin Neuropharmacol. 2002 May-Jun; 25(3):174-81.